RECORD focuses on the R&D of API-medical intermediates, fine chemical products and the concerned marketing business. Record takes fluoration, bromation, hydrogenation, Grignard reaction and asymmetric reaction as our first technologies. Our main products include Aztreonam, Cilostazol, Trilostane, Ticarcillin Disodium, Idebenone, Mucobromic Acid, 6-Methyl-nicotinic acid methyl ester, 6-Trifluoromethyl Nicotinic acid and the intermediate, etc. We are strong in R&D and do customer synthesis for our customers in every country. Welcome to know more about us from www.recordpharm.com and cooperate with us!